m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

肿瘤科 医学 血液学 内科学 化疗 肺癌 癌症 癌症研究
作者
Zhihui Zhang,Chaoqi Zhang,Zhaoyang Yang,Guochao Zhang,Peng Wu,Yuejun Luo,Qingpeng Zeng,Lide Wang,Qi Xue,Yi Zhang,Nan Sun,Jie He
出处
期刊:Journal of Hematology & Oncology [BioMed Central]
卷期号:14 (1) 被引量:45
标识
DOI:10.1186/s13045-021-01173-4
摘要

Abstract Small-cell lung cancer (SCLC) is a devastating subtype of lung cancer with few therapeutic options. Despite the advent of immunotherapy, platinum-based chemotherapy is still the irreplaceable first-line therapy for SCLCs. However, drug resistance will invariably occur in most patients and the outcomes are heterogeneous. Therefore, clinically feasible classification strategies and potential therapeutic targets for overcoming chemotherapy resistance are urgently needed. N 6 -methyladenosine (m 6 A) is a novel epigenetic decisive factor that is involved in tumor progression and drug resistance. However, almost nothing is known about m 6 A modification in SCLC. Here, we assessed 200 SCLC samples from patients who underwent chemotherapy from three different cohorts, including a validation cohort containing 71 cases with qPCR data and an independent cohort containing 79 cases with immunohistochemistry data (quantified as H-score). We systematically characterized the predictive landscape of m 6 A regulators in SCLC patients following with chemotherapy. Using the LASSO Cox model, we built a seven-regulator-based ( ZCCHC4 , IGF2BP3 , ALKBH5 , YTHDF3 , METTL5 , G3BP1 , and RBMX ) chemotherapy benefit predictive classifier (m 6 A score) and subsequently validated the classifier in two other cohorts. Time-dependent ROC and C-index analyses showed that the m 6 A score to possessed superior predictive power for chemotherapy benefit in comparison with other clinicopathological parameters. A multicohort multivariate analysis revealed that the m 6 A score is an independent factor that affects survival benefit across multiple cohorts. Our in vitro experimental results revealed that three regulators—ZCCHC4, G3BP1, and RBMX—may serve as promising novel therapeutic targets for overcoming chemoresistance in SCLCs. Our results, for the first time, demonstrate the predictive significance of m 6 A regulators for chemotherapy benefit, as well as their potential as therapeutic targets for overcoming chemotherapy resistance in SCLC patients. The m 6 A score was found to be a reliable prognostic tool that may help guide chemotherapy decisions for patients with SCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
落霞与孤鹜齐飞完成签到,获得积分20
刚刚
乐观的忆枫完成签到,获得积分10
刚刚
Rondab应助曲夜白采纳,获得10
刚刚
活泼水桃完成签到,获得积分10
刚刚
1秒前
Naomi发布了新的文献求助10
1秒前
刻苦千琴完成签到,获得积分10
1秒前
量子星尘发布了新的文献求助10
1秒前
chris发布了新的文献求助10
1秒前
tcf发布了新的文献求助10
1秒前
2秒前
ww完成签到,获得积分10
2秒前
弦歌完成签到 ,获得积分10
3秒前
喜多米430完成签到,获得积分10
3秒前
cnkly完成签到,获得积分10
3秒前
HI完成签到 ,获得积分10
3秒前
小学霸搞科研完成签到 ,获得积分10
4秒前
在九月完成签到 ,获得积分10
5秒前
5秒前
revo完成签到,获得积分10
5秒前
小二郎应助等待盼雁采纳,获得10
5秒前
曲夜白完成签到,获得积分10
5秒前
高兴的书竹完成签到,获得积分20
5秒前
6秒前
lslfreedom发布了新的文献求助10
7秒前
7秒前
Sun发布了新的文献求助10
7秒前
小马甲应助不靠谱采纳,获得10
7秒前
烟花应助GSGSG采纳,获得10
8秒前
lh完成签到,获得积分10
8秒前
GOW完成签到,获得积分10
8秒前
隔壁小曾发布了新的文献求助10
9秒前
9秒前
科研通AI2S应助山雀采纳,获得10
9秒前
huhu完成签到 ,获得积分10
10秒前
czj完成签到 ,获得积分10
10秒前
hz52发布了新的文献求助10
10秒前
九卫完成签到 ,获得积分20
11秒前
多喝热水完成签到,获得积分10
11秒前
月月月鸟伟完成签到,获得积分10
12秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
A new approach to the extrapolation of accelerated life test data 1000
徐淮辽南地区新元古代叠层石及生物地层 500
Coking simulation aids on-stream time 450
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4015939
求助须知:如何正确求助?哪些是违规求助? 3555887
关于积分的说明 11319237
捐赠科研通 3288997
什么是DOI,文献DOI怎么找? 1812357
邀请新用户注册赠送积分活动 887882
科研通“疑难数据库(出版商)”最低求助积分说明 812044